EH-42, a novel small molecule induces apoptosis and inhibits migration and invasion of human hepatoma cells through suppressing STAT3 signaling pathway.

CONCLUSIONS: Taken together, these findings suggested that EH-42 could be a potential therapeutic agent for HCC treatment.
PMID: 30585547 [PubMed - as supplied by publisher]

Source: Current Cancer Drug Targets - December 25, 2018 Category: Cancer & Oncology Authors: Gong QZ, Xiao D, Gong GY, Xu J, Wen XD, Feng F, Qu W Tags: Curr Cancer Drug Targets Source Type: research